These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1898847)

  • 21. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition.
    Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J
    Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection.
    Busillo CP; Lessnau KD; Sanjana V; Soumakis S; Davidson M; Mullen MP; Talavera W
    Chest; 1992 Sep; 102(3):797-801. PubMed ID: 1516405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence.
    Samb B; Sow PS; Kony S; Maynart-Badiane M; Diouf G; Cissokho S; Bâ D; Sané M; Klotz F; Faye-Niang MA; Mboup S; Ndoye I; Delaporte E; Hane AA; Samb A; Coulaud JP; Coll-Seck AM; Larouzé B; Murray JF
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):330-6. PubMed ID: 10206504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emergence of drug-resistant tuberculosis in New York City.
    Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
    N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
    Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
    Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis.
    Asch S; Knowles L; Rai A; Jones BE; Pogoda J; Barnes PF
    Am J Respir Crit Care Med; 1996 May; 153(5):1708-10. PubMed ID: 8630625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire.
    Perriëns JH; Colebunders RL; Karahunga C; Willame JC; Jeugmans J; Kaboto M; Mukadi Y; Pauwels P; Ryder RW; Prignot J
    Am Rev Respir Dis; 1991 Oct; 144(4):750-5. PubMed ID: 1928943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study.
    Pitchenik AE; Burr J; Suarez M; Fertel D; Gonzalez G; Moas C
    Am Rev Respir Dis; 1987 Apr; 135(4):875-9. PubMed ID: 3645999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation of Mycobacterium tuberculosis with primary resistance to chemotherapeutic agents in patients with HIV infection].
    Sesma P; Esteban J; Gegundez MI; Manrique A; Espinosa P; Fernández-Guerrero ML
    Enferm Infecc Microbiol Clin; 1992; 10(7):416-20. PubMed ID: 1450261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda.
    Eriki PP; Okwera A; Aisu T; Morrissey AB; Ellner JJ; Daniel TM
    Am Rev Respir Dis; 1991 Jan; 143(1):185-7. PubMed ID: 1986677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P; Were M
    Tuber Lung Dis; 1993 Dec; 74(6):377-81. PubMed ID: 8136490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pattern of human immunodeficiency virus infection (HIV) in pulmonary tuberculosis patients in Jos, Nigeria.
    Anteyi EA; Idoko JA; Ukoli CO; Bello CS
    Afr J Med Med Sci; 1996 Dec; 25(4):317-21. PubMed ID: 9532299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance among new smear-positive pulmonary tuberculosis cases in Thailand.
    Kateruttanakul P; Unsematham S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):814-7. PubMed ID: 23676168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of mycobacterial species in clinically diagnosed cases of pulmonary tuberculosis and their HIV status.
    Patwardhan NS; Bansal MP; Pradhan J
    Indian J Pathol Microbiol; 1997 Jul; 40(3):365-7. PubMed ID: 9354009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical research on human immunodeficiency virus seropositive patients with pulmonary tuberculosis].
    Wang W; Cram AR; Micah ST
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):663-5. PubMed ID: 11225029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS.
    Shafer RW; Goldberg R; Sierra M; Glatt AE
    Am Rev Respir Dis; 1989 Dec; 140(6):1611-3. PubMed ID: 2513763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
    Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of tuberculosis in parenteral drug addicts with human immunodeficiency virus seropositivity. A cohort study in detoxication communities].
    Solera J; López E; Serna E; Vergara L; Martínez-Alfaro E; Sáez L
    Med Clin (Barc); 1993 May; 100(19):725-9. PubMed ID: 8315960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients.
    Ratanasuwan W; Kreiss JK; Nolan CM; Schaeffler BA; Suwanagool S; Tunsupasawasdikul S; Chuchottaworn C; Dejsomritrutai W; Foy HM
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):259-64. PubMed ID: 9432374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.